Management of Displaced Supracondylar Fractures of the Humerus Using Lateral vs. Crossed K-wires
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00358787|
Recruitment Status : Completed
First Posted : August 1, 2006
Last Update Posted : January 10, 2018
|Condition or disease||Intervention/treatment||Phase|
|Humeral Fractures||Procedure: Crossed K-wiring of supracondylar fracture of the humerus Procedure: Lateral K-wiring of supracondylar fracture of the humerus||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||55 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Management of Displaced Supracondylar Fractures of the Humerus Using Lateral Versus Cross K Wires: A Prospective Randomized Clinical Trial|
|Study Start Date :||July 2008|
|Actual Primary Completion Date :||November 2017|
|Actual Study Completion Date :||November 2017|
Active Comparator: 1
Crossed K wire orientation for surgical management of a type III Supracondylar fracture.
Procedure: Crossed K-wiring of supracondylar fracture of the humerus
Closed reduction of the fracture followed by crossed K wire percutaneous pinning.
Active Comparator: 2
Lateral K wire orientation for surgical management of a type III Supracondylar fracture.
Procedure: Lateral K-wiring of supracondylar fracture of the humerus
Closed reduction of the fracture followed by lateral K wire percutaneous pinning.
- Loss of reduction between lateral K wires and crossed K wires in the treatment of supracondylar fractures of the humerus (at pin removal)
- Functional outcome (3 years post-op) [ Time Frame: 3 years ]
- Rate of iatrogenic ulnar nerve injury
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00358787
|Canada, British Columbia|
|British Columbia Children's Hospital|
|Vancouver, British Columbia, Canada, V6H 3V4|
|Principal Investigator:||Kishore Mulpuri, MD||The University of British Columbia|